OnKure Therapeutics OKUR Income Statement (2020-2026)

NASDAQ OKUR
$3.93 -0.15 (-3.68%)
At close: Aug 20, 2026 · 4:00 PM EDT
Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & Cost
Interest income
Interest Income - Total (Quarter)
0.29M0.23M0.17M1.31M1.07M0.93M0.80M0.63M0.46M1.55M
Interest expenses
Interest Expenses (Quarter)
8.87M13.53M0.38M1.62M0.73M0.10M11.87M14.01M19.17M-0.10M0.05M0.85M0.09M0.21M0.14M0.85M0.70M0.14M0.14M0.84M
Interest Income - Net (Quarter)
0.24M0.20M-0.04M1.26M1.07M0.93M0.80M0.62M0.46M1.55M
Non-interest income
Investment Gain (Loss) (Quarter)
-0.05M
Non-Interest Income (Quarter)
-0.05M
Operating Items
Research & Development (Quarter)
9.32M7.10M9.28M8.13M9.94M10.36M10.99M14.40M13.62M-6.89M8.57M10.75M10.12M14.36M13.01M12.61M11.91M10.72M11.71M12.61M
Selling, General & Administrative (Quarter)
3.43M3.52M3.74M4.30M3.90M4.21M5.13M6.64M7.27M-14.22M1.26M3.59M1.40M4.34M3.99M3.71M3.59M3.40M3.91M4.29M
Operating Expenses (Quarter)
12.75M10.62M13.02M12.43M13.84M14.56M16.12M21.04M20.89M-21.11M9.83M14.34M11.51M18.70M17.00M16.32M15.50M14.12M15.62M16.90M
Operating Income (Quarter)
-12.75M-10.62M-13.02M-12.43M-13.84M-14.56M-16.12M-21.04M-20.89M21.11M-9.83M-14.34M-11.51M-18.70M-17.00M-16.32M-15.50M-14.12M-15.62M-16.90M
EBIT (Quarter)
-12.75M-10.62M-13.02M-12.43M-13.84M-14.56M-16.12M-21.04M-20.89M21.11M-9.83M-14.34M-11.51M-18.70M-17.00M-16.32M-15.50M-14.12M-15.62M-16.90M
Non-operating items
Non Operating Interest Expenses (Quarter)
0.03M0.22M0.06M0.00M0.01M
Other Non Operating Income (Quarter)
0.02M0.02M-0.02M0.12M0.83M0.96M1.02M1.51M1.69M1.45M1.14M1.00M0.97M
Net income details
EBT (Quarter)
-21.62M-24.15M-13.39M-14.05M-14.57M-14.66M-28.00M-35.04M-40.06M21.22M-9.88M-15.19M-11.60M-18.91M-17.14M-17.17M-16.21M-14.27M-15.76M-17.73M
Profit After Tax (Quarter)
-12.73M-10.59M-13.04M-12.31M-13.01M-13.54M-15.11M-19.53M-19.19M18.52M-9.54M-14.14M-11.56M-17.44M-15.93M-15.39M-14.70M-13.50M-15.16M-15.36M
Income from Non-Controlling Interests (Quarter)
0.01M0.02M0.03M0.10M-0.19M-0.02M0.06M-0.04M0.01M0.03M-0.02M-0.00M0.01M-0.01M
Income from Continuing Operations (Quarter)
-21.62M-24.15M-13.39M-14.05M-14.57M-14.66M-28.00M-35.04M-40.06M21.22M-9.88M-15.19M-11.60M-18.91M-17.14M-17.17M-16.21M-14.27M-15.76M-17.73M
Consolidated Net Income (Quarter)
-21.62M-24.15M-13.39M-14.05M-14.57M-14.66M-28.00M-35.04M-40.06M21.22M-9.88M-15.19M-11.60M-18.91M-17.14M-17.17M-16.21M-14.27M-15.76M-17.73M
Income towards Parent Company (Quarter)
-21.62M-24.15M-13.39M-14.05M-14.57M-14.66M-28.00M-35.04M-40.06M21.22M-9.88M-15.19M-11.60M-18.91M-17.14M-17.17M-16.21M-14.27M-15.76M-17.73M
Net Income towards Common Stockholders (Quarter)
-21.62M-24.15M-13.39M-14.05M-14.57M-14.66M-28.00M-35.04M-40.06M21.22M-9.88M-15.19M-11.60M-18.91M-17.14M-17.17M-16.21M-14.27M-15.76M-17.73M
Additional items
EPS (Basic) (Quarter)
-8.86-13.31-5.48-5.74-5.95-5.99-11.18-11.60-11.856.92-2.96-4.55-3.47-5.48-1.28-1.27-1.20-1.06-1.15-0.36
EPS (Diluted) (Quarter)
-8.86-13.31-5.48-5.74-5.95-5.99-11.18-11.60-11.856.92-2.96-4.55-3.47-5.48-1.28-1.27-1.20-1.06-1.15-0.36
Shares Outstanding (Quarter)
2.44M1.81M2.45M2.45M2.45M2.45M2.50M3.02M3.38M3.07M3.34M3.34M3.34M3.45M13.42M13.51M13.53M13.52M13.67M49.87M
Shares Outstanding (Diluted) (Quarter)
2.44M1.81M2.45M2.45M2.45M2.45M2.50M3.02M3.38M3.07M3.34M3.34M3.34M3.45M13.42M13.51M13.53M13.52M13.67M49.87M
Shares Outstanding (Entity) (Quarter)
2.44M1.81M2.45M2.45M2.45M2.47M2.51M3.38M3.39M3.34M3.34M3.34M3.34M3.45M12.76M12.84M12.86M13.67M13.67M40.50M
EBITDA (Quarter)
-12.75M-10.62M-13.02M-12.43M-13.84M-14.56M-16.12M-21.04M-20.89M21.11M-9.83M-14.34M-11.51M-18.70M-17.00M-16.32M-15.50M-14.12M-15.62M-16.90M